CY1124777T1 - Παρασκευη παραγωγων του 2-([1,2,3]τριαζολ-2-υλ)-βενζοϊκου οξεος - Google Patents

Παρασκευη παραγωγων του 2-([1,2,3]τριαζολ-2-υλ)-βενζοϊκου οξεος

Info

Publication number
CY1124777T1
CY1124777T1 CY20211100871T CY211100871T CY1124777T1 CY 1124777 T1 CY1124777 T1 CY 1124777T1 CY 20211100871 T CY20211100871 T CY 20211100871T CY 211100871 T CY211100871 T CY 211100871T CY 1124777 T1 CY1124777 T1 CY 1124777T1
Authority
CY
Cyprus
Prior art keywords
triazol
benzoic acid
preparation
acid derivatives
formula
Prior art date
Application number
CY20211100871T
Other languages
English (en)
Inventor
Patric DÖRRWÄCHTER
Gunther Schmidt
Original Assignee
Idorsia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idorsia Pharmaceuticals Ltd filed Critical Idorsia Pharmaceuticals Ltd
Publication of CY1124777T1 publication Critical patent/CY1124777T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/70—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of the iron group metals or copper
    • B01J23/72—Copper
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Η παρούσα εφεύρεση αναφέρεται σε μία μέθοδο για την παρασκευή συγκεκριμένων παραγώγων του 2-(2Η-[1,2,3]τριαζολ-2-υλ)-βενζοϊκού οξέος του τύπου (Ι), σε ορισμένες κρυσταλλικές μορφές αλάτων με κάλιο των εν λόγω παραγώγων του 2-(2Η-[1,2,3]τριζολ-2-υλ)-βενζοϊκού οξέος του τύπου (Ικ), σε ορισμένες κρυσταλλικές μορφές των εν λόγω παραγώγων του 2-(2Η-[1,2,3]τριαζολ-2-υλ)-βενζοϊκού οξέος του τύπου (Ι) και στη χρήση τους στην παρασκευή φαρμακευτικών προϊόντων όπως η (S)-(2-(5-χλωρο-4-μεθυλο-1Η-βενζο[d]ιμιδαζολ-2-υλ)-2-μεθυλοπυρρολιδιν-1-υλ)-(5-μεθοξυ-2-(2Η-1,2,3-τριαζολ-2-υλ) φαινυλ)μεθανόνη.
CY20211100871T 2017-05-03 2021-10-06 Παρασκευη παραγωγων του 2-([1,2,3]τριαζολ-2-υλ)-βενζοϊκου οξεος CY1124777T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP2017060451 2017-05-03
PCT/EP2018/061172 WO2018202689A1 (en) 2017-05-03 2018-05-02 Preparation of 2-([1,2,3]triazol-2-yl)-benzoic acid derivatives

Publications (1)

Publication Number Publication Date
CY1124777T1 true CY1124777T1 (el) 2022-11-25

Family

ID=62116854

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20211100871T CY1124777T1 (el) 2017-05-03 2021-10-06 Παρασκευη παραγωγων του 2-([1,2,3]τριαζολ-2-υλ)-βενζοϊκου οξεος

Country Status (20)

Country Link
US (1) US11124488B2 (el)
EP (1) EP3619199B1 (el)
JP (1) JP7182562B2 (el)
KR (1) KR102582197B1 (el)
CN (1) CN110612291B (el)
CA (1) CA3059394C (el)
CY (1) CY1124777T1 (el)
DK (1) DK3619199T3 (el)
ES (1) ES2892161T3 (el)
HR (1) HRP20211304T1 (el)
HU (1) HUE055904T2 (el)
IL (1) IL270274B (el)
LT (1) LT3619199T (el)
MX (1) MX2019012902A (el)
PL (1) PL3619199T3 (el)
PT (1) PT3619199T (el)
RS (1) RS62357B1 (el)
SI (1) SI3619199T1 (el)
TW (1) TWI756418B (el)
WO (1) WO2018202689A1 (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112022020924A2 (pt) 2020-04-19 2023-02-14 Idorsia Pharmaceuticals Ltd Métodos de tratamento de um transtorno do sono, a sonolência diurna em um indivíduo, a insônia, e, daridorexante na forma de sal livre ou farmaceuticamente aceitável
TW202400149A (zh) 2022-05-13 2024-01-01 瑞士商愛杜西亞製藥有限公司 經噻唑并芳基-甲基取代之環狀肼-n-甲醯胺衍生物

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2069332B1 (en) 2006-08-15 2011-03-02 Actelion Pharmaceuticals Ltd. Azetidine compounds as orexin receptor antagonists
ES2350460T3 (es) 2006-09-29 2011-01-24 Actelion Pharmaceuticals Ltd. Derivados de 3-aza-biciclo[3.1.0]hexano.
PE20081229A1 (es) * 2006-12-01 2008-08-28 Merck & Co Inc Antagonistas de receptor de orexina de diazepam sustituido
AR064561A1 (es) 2006-12-28 2009-04-08 Actelion Pharmaceuticals Ltd Derivados de 2-aza-biciclo[3.1.0]hexano y su uso en la preparacion de un medicamento para el tratamiento de enfermedades relacionadas con disfunciones generales del sistema de la orexina.
DE602008002934D1 (de) 2007-05-14 2010-11-18 Actelion Pharmaceuticals Ltd 2-cyclopropylthiazolderivate
CA2687230A1 (en) 2007-05-23 2008-12-11 Merck & Co., Inc. Cyclopropyl pyrrolidine orexin receptor antagonists
JP5848251B2 (ja) 2009-10-23 2016-01-27 ヤンセン ファーマシューティカ エヌ．ベー． オレキシン受容体調節因子としての縮合複素環式化合物
EP2491034B1 (en) * 2009-10-23 2013-12-18 Janssen Pharmaceutica, N.V. Fused heterocyclic compounds as orexin receptor modulators
JP5759470B2 (ja) 2009-10-23 2015-08-05 ヤンセン ファーマシューティカ エヌ．ベー． オレキシン受容体調節因子としての二置換オクタヒドロピロロ［３，４−ｃ］ピロール
CA2821893A1 (en) 2010-12-17 2012-06-21 Taisho Pharmaceutical Co., Ltd. Pyrazole derivative
WO2012085852A1 (en) 2010-12-22 2012-06-28 Actelion Pharmaceuticals Ltd 3,8-diaza-bicyclo[4.2.0]oct-8-yl amides
US9108959B2 (en) 2011-03-03 2015-08-18 Merck Sharp & Dohme Corp. Process for the preparation of an orexin receptor antagonist
WO2012145581A1 (en) * 2011-04-20 2012-10-26 Janssen Pharmaceutica Nv Disubstituted octahy-dropyrrolo [3,4-c] pyrroles as orexin receptor modulators
JPWO2013005755A1 (ja) 2011-07-05 2015-02-23 大正製薬株式会社 メチルピペリジン誘導体
WO2013050938A1 (en) 2011-10-04 2013-04-11 Actelion Pharmaceuticals Ltd 3,7-diazabicyclo[3.3.1]nonane and 9-oxa-3,7-diazabicyclo[3.3.1]nonane derivatives
SG11201401665WA (en) 2011-11-08 2014-09-26 Actelion Pharmaceuticals Ltd 2-(1,2,3-triazol-2-yl)benzamide and 3-(1,2,3-triazol-2-yl)picolinamide derivatives as orexin receptor antagonists
US9441254B2 (en) 2012-05-09 2016-09-13 Merck Sharp & Dohme Corp. Process for the preparation of an intermediate for an orexin receptor antagonist
CN104334544B (zh) 2012-06-04 2016-10-19 埃科特莱茵药品有限公司 苯并咪唑脯氨酸衍生物
JP2014015452A (ja) 2012-06-15 2014-01-30 Taisho Pharmaceutical Co Ltd ピラゾール誘導体を含有する医薬
EA201500399A1 (ru) * 2012-10-10 2015-09-30 Актелион Фармасьютиклз Лтд. Антагонисты рецептора орексина, которые представляют собой производные [орто-би-(гетеро)арил]-[2-(мета-би-(гетеро)арил)пирролидин-1-ил]метанона
CA2902135A1 (en) 2013-03-12 2014-09-18 Actelion Pharmaceuticals Ltd Azetidine amide derivatives as orexin receptor antagonists
TW201444849A (zh) 2013-03-13 2014-12-01 Janssen Pharmaceutica Nv 經取代的7-氮雜雙環類及其作為食慾激素受體調節劑之用途
TW201444821A (zh) 2013-03-13 2014-12-01 Janssen Pharmaceutica Nv 經取代之哌啶化合物及其作為食慾素受體調節劑之用途
TWI664177B (zh) * 2013-12-03 2019-07-01 瑞士商愛杜西亞製藥有限公司 晶形
UA119151C2 (uk) 2013-12-03 2019-05-10 Ідорсія Фармасьютікалз Лтд КРИСТАЛІЧНА СОЛЬОВА ФОРМА (S)-(2-(6-ХЛОР-7-МЕТИЛ-1H-БЕНЗО[d]ІМІДАЗОЛ-2-ІЛ)-2-МЕТИЛПІРОЛІДИН-1-ІЛ)(5-МЕТОКСИ-2-(2H-1,2,3-ТРИАЗОЛ-2-ІЛ)ФЕНІЛ)МЕТАНОНУ ЯК АНТАГОНІСТ ОРЕКСИНОВОГО РЕЦЕПТОРА
UA116053C2 (uk) 2013-12-04 2018-01-25 Ідорсія Фармасьютікалз Лтд Застосування похідних бензоімідазолу-проліну
WO2015123355A1 (en) * 2014-02-12 2015-08-20 Eolas Therapeutics, Inc. Substituted prolines / piperidines as orexin receptor antagonists
WO2016020403A1 (en) 2014-08-04 2016-02-11 Sandoz Ag Preparation of a benzoic acid derivative and its use for the preparation of suvorexant
CN104649983B (zh) * 2014-12-23 2018-01-23 广东东阳光药业有限公司 一种酸的制备方法
JP6698633B2 (ja) * 2015-04-24 2020-05-27 武田薬品工業株式会社 複素環化合物

Also Published As

Publication number Publication date
HUE055904T2 (hu) 2021-12-28
RS62357B1 (sr) 2021-10-29
DK3619199T3 (da) 2021-09-27
JP7182562B2 (ja) 2022-12-02
EP3619199B1 (en) 2021-07-07
TWI756418B (zh) 2022-03-01
IL270274B (en) 2022-08-01
PT3619199T (pt) 2021-10-01
EP3619199A1 (en) 2020-03-11
WO2018202689A1 (en) 2018-11-08
CA3059394C (en) 2023-09-12
ES2892161T3 (es) 2022-02-02
MX2019012902A (es) 2019-12-16
US20210114997A1 (en) 2021-04-22
JP2020518573A (ja) 2020-06-25
LT3619199T (lt) 2021-09-27
CN110612291B (zh) 2024-02-13
CN110612291A (zh) 2019-12-24
CA3059394A1 (en) 2018-11-08
KR102582197B1 (ko) 2023-09-22
PL3619199T3 (pl) 2021-12-20
HRP20211304T1 (hr) 2021-11-12
US11124488B2 (en) 2021-09-21
KR20200003097A (ko) 2020-01-08
IL270274A (el) 2019-12-31
TW201843144A (zh) 2018-12-16
SI3619199T1 (sl) 2021-11-30

Similar Documents

Publication Publication Date Title
CY1124959T1 (el) Αναστολεις λυσινης ειδικης απομεθυλασης-1
CY1120941T1 (el) Παραγωγα φαινυλοτριαζολιου υποκατεστημενα με υδροξυαλκυλιο και χρησεις αυτων
MD3468974T2 (ro) Noi derivați de piperidinil, procedeu pentru prepararea lor și compoziții farmaceutice care ii conțin
MD3468971T2 (ro) Noi derivați de piperidinil (hetero)aril-substituiţi, procedeu de obţinere a acestora și compoziții farmaceutice care îi conțin
CY1123595T1 (el) Παραγωγα χολικου οξεος ως αγωνιστες fxr/tgr5
CY1123333T1 (el) Παραγωγα ινδολινονης και διαδικασια για την παραγωγη τους
CY1124855T1 (el) 2-(μορφολιν-4-υλ)-1,7-ναφθυριδινες
CY1124777T1 (el) Παρασκευη παραγωγων του 2-([1,2,3]τριαζολ-2-υλ)-βενζοϊκου οξεος
CY1122730T1 (el) 1,2,4-τριαζολες ως διαμορφωτες πυρηνικης μεταφορας και χρησεις αυτων
CY1122325T1 (el) Ενωσεις ρυθμισης fxr (nr1h4)
MX2020004932A (es) Compuestos utiles para inhibir a cdk7.
PE20181298A1 (es) Inhibidores de bromodominio bivalentes y usos de los mismos
DOP2010000343A (es) Derivados de quinolinas y quinoxalinas como inhibidores de cinasa de proteina tirosina
UY31631A1 (es) Nuevos derivados de 7-fenil-7h-pirrolo-[2,3d]-pirimidin-2-il-amino, sales de los mismos, procesos para su preparacion, composiciones farmacéuticas que los comprenden y aplicaciones
MD3313850T2 (ro) Noi derivaţi de aminoacizi, procedeu pentru prepararea acestora şi compoziţii farmaceutice care îi conţin
CY1117962T1 (el) Υδροχλωρικο αλας 4-[2-[[5-μεθυλο-1-(2- ναφθαλενυλο)-1η- πυραζολ-3-υλ]οξυ]αιθυλο] μορφολινης
CY1124088T1 (el) Παραγωγα 2,4-θειαζολιδινεδιονης στη θεραπεια διαταραχων του κεντρικου νευρικου συστηματος
CR20140057A (es) Compuestos fungicidas de 1-{2-[2-halo-4-(4-halogen-fenoxi)-fenil]-2-etoxi-etil}-1h-[1,2,4]triazol sustituidos
CL2019003281A1 (es) Derivados de piperidina. (divisional solicitud 201900169)
ECSP099327A (es) Nuevos derivados de 1,4-benzotiepina-1,1-dióxido sustituidos con radicales bencilo, método para su preparación, productos farmacéuticos que comprenden estos compuestos y su uso
CY1113178T1 (el) Σταθεροποιημενες αμορφες μορφες της μεσυλικης ιματινιβης
DOP2006000076A (es) Derivados de ciclopentapiridina y tetrahidroquinolina
CY1119687T1 (el) Κρυσταλλικο αλας της (s)-(2-(6-χλωρο-7- μεθυλ-1η- βενζο [d]imiδazoλ-2- υλ)-2- μεθυλπυρρολιδιν-1- υλ)(5-μεθοξυ-2-(2η-1,2,3- τριαζολ-2- υλ)φαινυλ) μεθανονης ως ανταγωνιστης υποδοχεα ορεξινης
CY1116168T1 (el) Συγκρυσταλλοι και αλατα αναστολεων toy ccr3
CY1124528T1 (el) Ν-υποκατεστημενα παραγωγα ινδολης